Koya Yamashita,Zhilei Zhao,Keita Saito et al.
Koya Yamashita et al.
Hyperpolarized magnetic resonance imaging (MRI) has emerged as a transformative tool in cancer diagnostics, enabling real-time, non-invasive assessment of tumor metabolism. By employing hyperpolarized molecular probes, such as [1-13C]pyruva...
Comparative analysis of pancreatic cancer burden attributable to high BMI in adults aged 70 and older: analysis of the GBD data in the United States, Australia, and Germany (2012-2021) [0.03%]
基于GBD数据的美国、澳大利亚和德国成人中老年人群超重所致胰腺癌疾病负担的比较分析（2012-2021年）
Hanwen Yang,Simeng Lei,Yangkai Fu et al.
Hanwen Yang et al.
Background: Pancreatic cancer (PC) is a highly lethal malignancy for which obesity is a major risk factor. With increasing global aging, the burden of PC is increasing in the elderly population. ...
Case Report: Ablation as novel x therapy in the regimen for frail hematological malignancies with extramedullary lesion [0.03%]
病例报告：在虚弱的血液系统恶性肿瘤（伴有髓外病变）方案中使用消融作为新型x疗法
Muyun Wu,Shanshan Shi,Yan Guo et al.
Muyun Wu et al.
Hematological diseases, as a category of malignant tumors originating from the hematopoietic system, have long relied on treatments such as chemotherapy, radiotherapy, and hematopoietic stem cell transplantation. However, challenges remain ...
The effect of enhanced recovery after surgery on the risk factors of venous thromboembolism for patients with gynecologic malignancies [0.03%]
加速康复护理路径对妇科恶性肿瘤患者静脉血栓栓塞症危险因素的影响研究
Jie Xu,Shanshan Liu,Dan Liu et al.
Jie Xu et al.
Objective: This study aims to evaluate the efficacy of enhanced recovery after surgery (ERAS) in mitigating the risk of venous thrombosis in patients undergoing surgery for gynecological malignancies. ...
HER2-targeted therapy combined with multidisciplinary management in advanced gallbladder cancer: a case report with 90-month survival [0.03%]
HER2导向疗法联合多学科综合治疗晚期胆囊癌一例（随访90个月）
Yulin Wang,Guangwei Tian,Yu Cheng et al.
Yulin Wang et al.
Biliary tract malignancies are highly lethal, with a 5-year overall survival (OS) rate of less than 10%. This report describes a patient with HER2-positive advanced gallbladder cancer who achieved an OS of 90 months through multidisciplinar...
Efficacy and safety of sorafenib combined with transarterial chemoembolization in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials [0.03%]
索拉非尼联合肝动脉化疗栓塞治疗肝细胞癌的疗效和安全性：随机对照试验的meta分析研究
Lixiu Yu,Yi Xiong,Jing Liao et al.
Lixiu Yu et al.
Objective: Transarterial chemoembolization (TACE) plus sorafenib has led to an increase in randomized controlled trials The efficacy and safety of sorafenib combined with TACE for the treatment of hepatocellular carcinoma...
Laparoscopic hepaticopancreaticoduodenectomy for synchronous intrahepatic cholangiocarcinoma and distal common bile duct tumors: a case report [0.03%]
腹腔镜肝胰十二指肠切除术治疗同期发生的肝内胆管癌和远端胆总管肿瘤：1例报告
Yuhui Fang,Dongdong Huang,Yuquan Chang et al.
Yuhui Fang et al.
Background: Laparoscopic hepatopancreatoduodenectomy (LHPD) is a while very complex procedure for biliary malignancies combined with intrahepatic bile duct invasion, but there are few reports of related surgeries due to h...
Circulating DNA tumor fraction as a biomarker for advanced breast cancer [0.03%]
循环DNA肿瘤片段作为晚期乳腺癌生物标志物的研究
Emily Cybulla,Daniel G Stover
Emily Cybulla
Liquid biopsy has emerged as an important clinical tool for managing a range of tumor types, including advanced breast cancers. Early work in metastatic breast cancer (MBC) demonstrated that circulating tumor DNA (ctDNA) could be reliably d...
Rewiring tumor visibility: The immunopeptidome as a dynamic interface between antigen processing, microenvironmental stress, and immune recognition [0.03%]
重塑肿瘤的可见性：免疫肽组作为抗原处理、微环境压力和免疫识别之间的动态界面
Kangkang Zhao,Yunlan Huang,Linlin Chang et al.
Kangkang Zhao et al.
The tumor immunopeptidome dictates whether malignant cells remain visible or invisible to immune surveillance, yet its regulation extends far beyond canonical antigen processing. Here, we synthesize recent insights into how proteasomes, imm...
Comparative effectiveness and safety of immunotherapeutic strategies in ovarian cancer: a systematic review and network meta-analysis [0.03%]
卵巢癌免疫治疗策略的疗效和安全性比较：系统评价与网络Meta分析
Xinyao Wang,Yuli Zhang,Wei Xie et al.
Xinyao Wang et al.
Background: Ovarian cancer remains the most lethal gynecologic malignancy, with poor survival despite standard therapies. Immunotherapy represents a promising option, yet the comparative efficacy and safety among differen...